Ron Shore
YOU?
Author Swipe
View article: Behavioural investigations of psilocybin in non-human animals 1962–2021: A scoping review
Behavioural investigations of psilocybin in non-human animals 1962–2021: A scoping review Open
Background and Aims Psilocybin is a psychedelic compound that may hold promise for a wide range of human health conditions, yet the identification of therapeutic processes and mechanisms of action remains exploratory. We conducted a scopin…
View article: A framework to assess risks for non-medical use of psychedelics: The liability for abuse of psychedelics questionnaire (LAPQ)
A framework to assess risks for non-medical use of psychedelics: The liability for abuse of psychedelics questionnaire (LAPQ) Open
As psychedelic research moves forward, trial design could benefit from assessments of potential risks of treatment. One such risk is future abuse or misuse of the drug or other drugs of abuse. Like the ketamine literature, psychedelic stud…
View article: Behavioural Investigations of Psilocybin in Animals 1962-2021: A Scoping Review
Behavioural Investigations of Psilocybin in Animals 1962-2021: A Scoping Review Open
Background and Aims Psilocybin is a psychedelic drug that may hold promise for a wide range of human health conditions, yet the identification of therapeutic processes and mechanisms of action remains exploratory. We conducted a scoping re…
View article: Incidence and Survival of Multiple Primary Cancers in US Women With a Gynecologic Cancer
Incidence and Survival of Multiple Primary Cancers in US Women With a Gynecologic Cancer Open
Objectives To evaluate risk of a second cancer and associated survival times in United States women with diagnosis of cancer. Methods The Surveillance Epidemiology and End Results (SEER) database was queried for 2 cohorts of women aged 18 …
View article: Psychedelics, Safety and Clinical Trial Design
Psychedelics, Safety and Clinical Trial Design Open
Objectives: To investigate the safety of psychedelics for humans, to identify the limitations of the current evidence and to indicate how gaps and limitations may be addressed in future clinical trial design. Methodology: I completed a nar…
View article: Mapping Psilocybin-Assisted Therapies: A Scoping Review
Mapping Psilocybin-Assisted Therapies: A Scoping Review Open
We conducted a scoping review on psilocybin-assisted therapy for addiction, depression, anxiety and post-traumatic stress disorder. Psilocybin is a naturally-occurring tryptophan derivative found in species of mushroom with psycho-active p…